MANJULA KOTTAPALLI: Open Payments
NPI 1730201229 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 12 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $71 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Noven Therapeutics, LLC | 2 | $43 |
| Lundbeck LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
Products named: Azstarys, SPRAVATO, Xelstrym, REXULTI, TRINTELLIX, INGREZZA, VRAYLAR, COBENFY.
Industry payments across OH — which companies pay providers there.
